Notes
International Society for Pharmacoeconomics and Outcomes Research
Reference
Cicchetti A, et al. Cost-Effectiveness of a Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus a No Test Strategy. 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PMD67, 29 Oct 2016. Available from: URL: http://www.ispor.org/RESEARCH_STUDY_DIGEST/list.asp?qs=46834.
Rights and permissions
About this article
Cite this article
Preventive BRCA testing cost effective in relatives. PharmacoEcon Outcomes News 767, 27 (2016). https://doi.org/10.1007/s40274-016-3587-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3587-y